Incyte Corporation (INCY)
NASDAQ·Healthcare·Biotechnology
$122.02
-1.03%
Mkt Cap $25.69B
Analyst Ratings
Buy
19
Hold
5
Sell
0
Price Target (56 analysts)
$108.92
Range $90.00 – $140.00
Implied Upside
-10.7%
Consensus $108.92 vs current $122.02
NASDAQ·Healthcare·Biotechnology
$122.02
-1.03%
Mkt Cap $25.69B
Buy
19
Hold
5
Sell
0
Price Target (56 analysts)
$108.92
Range $90.00 – $140.00
-10.7%
Consensus $108.92 vs current $122.02